Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07489963

Functional Impact at 12 Months Post-op of Posterior Cruciate Ligament Conservation During Robotic-assisted Surgery (MAKO) for Total Knee Replacement.

Led by Centre Hospitalier Universitaire de Nīmes · Updated on 2026-03-27

300

Participants Needed

3

Research Sites

151 weeks

Total Duration

On this page

Sponsors

C

Centre Hospitalier Universitaire de Nīmes

Lead Sponsor

C

Clinique Tivoli Ducos

Collaborating Sponsor

AI-Summary

What this Trial Is About

Studies have been made on the best way to do knee surgery and whether to conserve the posterior cruciate ligament or not during total knee prosthesis insertion is still under debate. However, most of these studies were made before the introduction of robotic knee surgery. It seems timely to do a study comparing these two surgical techniques: preservation versus removal of the posterior cruciate ligament in knee arthroplasty

CONDITIONS

Official Title

Functional Impact at 12 Months Post-op of Posterior Cruciate Ligament Conservation During Robotic-assisted Surgery (MAKO) for Total Knee Replacement.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient scheduled for first-intention robotic-assisted total knee replacement (MAKO).
  • Unilateral replacement, regardless of laterality.
  • Patient able to answer questionnaires.
  • Patient willing to undergo usual 12-month follow-up.
  • Patient has given free and informed consent and has signed the consent form.
  • Patient affiliated with or benefiting from a health insurance scheme.
Not Eligible

You will not qualify if you...

  • Patient with intraoperative technical impossibility of retaining PCL (flessum > 20°, flexion stiffening < 100°).
  • Previous posterior cruciate ligament surgery.
  • Post-traumatic gonarthrosis.
  • Valgus > 185°.
  • Patient with septic complication.
  • Patient participating in another interventional trial.
  • Patient in an exclusion period determined by another study.
  • Patient under court protection, guardianship or curatorship.
  • Patient unable to give consent.
  • Patients for whom it is impossible to provide informed information.
  • Pregnant women

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Clinique Tivoli-Ducos

Bordeaux, France, 33000

Actively Recruiting

2

Hôpital Croix Rousse

Lyon, France, 69317

Actively Recruiting

3

Nîmes University Hospital

Nîmes, France, 30029

Actively Recruiting

Loading map...

Research Team

R

Rémy COULOMB, Dr

CONTACT

A

Anissa MEGZARI

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here